Zobrazeno 1 - 10
of 19
pro vyhledávání: '"M. J. W. Ijsseldijk"'
Autor:
Gijsbert van Willigen, Alan T. Nurden, Jasper A. Remijn, Jan J. Sixma, Ya-Ping Wu, M. J. W. Ijsseldijk, Philip G. de Groot, Paquita Nurden, Ellen H. Jeninga
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 22:686-691
ADP plays a central role in regulating platelet function. It induces platelet aggregation via the activation of 2 major ADP receptors, P2Y 1 and P2Y 12 . We have investigated the role of P2Y 12 in platelet adhesion and thrombus formation under physio
Autor:
C.G. Knight, Verkleij Mw, M. J. W. Ijsseldijk, G.J. Heijnen-Snyder, Laurence F. Morton, J. J. Sixma, de Groot Pg, Huizinga Eg, Mike Barnes
Publikováno v:
Thrombosis and Haemostasis. 82:1137-1144
Seven overlapping peptides derived from the bovine alpha1(III)CB4 fragment of collagen III support static platelet adhesion, and an integrin alpha2beta1-recognition site has been assigned within this fragment to residues 522-528 of the collagen alpha
Autor:
H. Lankhof, Tom Vink, C. Damas, Madelon Bracke, M. E. Schiphorst, P. G. De Groot, M. J. W. Ijsseldijk, J. J. Sixma, Miha Furlan
Publikováno v:
Thrombosis and Haemostasis. 81:976-983
SummaryType 2A von Willebrand Disease (vWD) is characterized by the absence of high molecular weight von Willebrand factor (vWF) multimers in plasma which is caused by enhanced extracellular proteolysis or defective intracellular transport. We identi
Autor:
Madelon Bracke, C. Damas, Marion E. Schiphorst, M. J. W. Ijsseldijk, Philip G. de Groot, Tom Vink, Jan J. Sixma, Hanneke Lankhof
Publikováno v:
Blood. 89:2766-2772
Type 2B von Willebrand disease (vWD) is characterized by the absence of the very high molecular weight von Willebrand factor (vWF ) multimers from plasma, which is caused by spontaneous binding to platelet receptor glycoprotein Ib (GPIb). We studied
Autor:
C. Damas, H. Lankhof, de Groot Pg, Han-Mou Tsai, Miha Furlan, Madelon Bracke, Jan J. Sixma, M. E. Schiphorst, M. J. W. Ijsseldijk, Tom Vink
Publikováno v:
Thrombosis and Haemostasis. 77:1008-1013
Summaryvon Willebrand factor (vWF) is a complex multimeric plasma glycoprotein, that plays a critical role in the mediation of platelet adhesion to the damaged vascular wall, and functions as a carrier protein for factor VIII. vWF has a domain struct
Autor:
M. E. Schiphorst, M. Van Hoeij, Madelon Bracke, H. Lankhof, P. G. De Groot, Jan J. Sixma, M. J. W. Ijsseldijk, Tom Vink, Ya Ping Wu
Publikováno v:
Thrombosis and Haemostasis. 75:950-958
von Willebrand factor (vWF) mediates platelet adhesion at sites of vascular damage. It acts as a bridge between receptors on platelets and collagens present in the connective tissue. Two collagen binding sites have been identified on the A1 and A3 do
Publikováno v:
Blood. 86:3452-3460
We describe glycoprotein (GP) Ib as a mediator of adhesion to fibronectin, specifically in flow. A monoclonal antibody (MoAb) directed to the von Willebrand factor (vWF)-binding site on this receptor or the absence of this receptor on the platelet me
Publikováno v:
Blood. 84:3724-3733
Platelet adhesion to purified surface-immobilized fibronectin under flow conditions was investigated. Fibronectin was found to support attachment and spreading of platelets. The extent of platelet spreading depended on the amount of immobilized fibro
Autor:
M. N. Boomgaard, C. W. N. Gouwerok, P. G. De Groot, Christa H. E. Homburg, Dirk de Korte, M. J. W. Ijsseldijk
Publikováno v:
Thrombosis and Haemostasis. 72:611-616
SummaryThe influence of storage of platelet concentrates (PC) on the adhesion capacity of platelets was studied. Twenty-four PC, 12 prepared by the buffy coat (BC) method and 12 by the platelet-rich plasma (PRP) method, were stored for 7 days at room
Autor:
Jan J. Sixma, Marco Moia, Philip G. de Groot, Augusto B. Federici, Pier Mannuccio Mannucci, M. J. W. Ijsseldijk
Publikováno v:
British Journal of Haematology. 83:88-93
Endothelial cells (EC) were isolated from the umbilical vein of a newborn girl with type I 'platelet low' von Willebrand disease (I vWD) and endothelial localization and release and the ability of subendothelial von Willebrand factor (vWF) to support